103 studies found for:    Open Studies | "Carcinoma, Ductal, Breast"
Show Display Options
Rank Status Study
21 Recruiting A Phase II Study of Neoadjuvant FOLFIRINOX
Condition: Resectable Pancreatic Ductal Adenocarcinoma
Intervention: Drug: FOLFIRINOX
22 Recruiting Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy
Conditions: Ductal Breast Carcinoma in Situ;   Invasive Ductal Breast Carcinoma;   Invasive Lobular Breast Carcinoma;   Lobular Breast Carcinoma in Situ;   Recurrent Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer
Interventions: Behavioral: Behavioral dietary intervention;   Procedure: Therapeutic conventional surgery;   Radiation: Radiation therapy;   Other: Counseling intervention;   Procedure: Quality-of-life assessment
23 Recruiting Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery
Conditions: Ductal Breast Carcinoma in Situ;   Estrogen Receptor-negative Breast Cancer;   Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Invasive Ductal Breast Carcinoma;   Lobular Breast Carcinoma in Situ;   Progesterone Receptor-positive Breast Cancer;   Stage I Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Procedure: therapeutic conventional surgery;   Radiation: radiation therapy;   Procedure: quality-of-life assessment
24 Not yet recruiting A Phase II Study of siG12D LODER in Combination With Chemotherapy in Patients With Unresectable Locally Advanced Pancreatic Cancer
Conditions: Pancreatic Ductal Adenocarcinoma;   Pancreatic Cancer
Interventions: Drug: siG12D LODER;   Drug: Gemcitabine or FOLFIRINOX
25 Recruiting Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer
Conditions: Invasive Breast Cancer (Stage I-III);   Ductal Carcinoma in Situ;   Lobular Carcinoma in Situ;   Lobular Carcinoma;   Fatigue Related to Cancer Treatment
Interventions: Drug: Naltrexone;   Drug: Sugar Pill
26 Unknown  Diagnostic Study of Early Breast Cancer Using Ultrasound
Condition: Ductal Carcinoma In-situ
Intervention: Drug: Perflutren lipid microsphere
27 Recruiting Study to Assess Perfusion and Patient Satisfaction in Nipple-Areola Mastectomy With Immediate Reconstruction
Conditions: Ductal Carcinoma in Situ (DCIS);   Clinical Stage I Breast Cancer;   Prophylactic Mastectomy
Interventions: Procedure: Inframammary Fold Incision or Lateral Radial Incision;   Procedure: Lateral Radial Incision;   Procedure: Inframammary Fold Incision;   Device: Laser-assisted fluorescence angiography
28 Unknown  Intraoperative Gamma Camera for Breast Cancer Surgery
Conditions: Breast Cancer;   Ductal Carcinoma in Situ
Intervention: Device: SLN procedure (CarolIReS camera)
29 Not yet recruiting =Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer
Conditions: Resectable Pancreatic Cancer;   Pancreatic Ductal Carcinoma
Interventions: Drug: FOLFIRINOX;   Drug: Gemcitabine/nab-Paclitaxel;   Radiation: Radiation therapy;   Drug: Capecitabine
30 Recruiting Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers
Conditions: Colorectal Cancer;   Gastric Adenocarcinoma;   Esophageal Cancer;   Hepatocellular Carcinoma;   Non-small Cell Lung Cancer;   Small Cell Lung Cancer;   Ovarian Epithelial Cancer;   Breast Cancer;   Hormone-refractory Prostate Cancer;   Pancreatic Ductal Adenocarcinoma;   Head and Neck Cancers- Squamous Cell;   Renal Cell Cancer;   Bladder Cancer
Intervention: Drug: IMMU-132
31 Not yet recruiting Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas
Conditions: Lung Adenocarcinoma;   Breast Adenocarcinoma;   Pancreatic Ductal Adenocarcinoma
Intervention: Other: their will be no intervention in any of the groups, the study is retrospective
32 Recruiting Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer
Condition: Carcinoma, Ductal, Breast
Interventions: Procedure: Biopsy before and after three weeks of study treatment;   Drug: Paclitaxel;   Drug: lapatinib;   Drug: trastuzumab
33 Recruiting Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ
Condition: Breast Cancer
Interventions: Drug: letrozole;   Procedure: adjuvant radiation;   Procedure: dynamic contrast-enhanced magnetic resonance imaging;   Procedure: adjuvant hormonal therapy;   Procedure: therapeutic conventional surgery
34 Recruiting Contrast-Enhanced MRI in Women With Ductal Breast Carcinoma in Situ and in Healthy Volunteers
Condition: Breast Cancer
Intervention: Procedure: contrast-enhanced magnetic resonance imaging
35 Recruiting Evaluation of the Diagnostic Performance of MRI±Biopsy to Optimize Resection of Ductal Carcinoma In Situ (DCIS) Breast Cancer
Condition: Breast Cancer
Intervention: Procedure: MRI±biopsy
36 Recruiting Nipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and Reconstruction
Conditions: Breast Cancer;   Ductal Carcinoma
Interventions: Procedure: Nipple-Sparing Mastectomy;   Radiation: Prophylactic Nipple-Areolar Complex RT;   Procedure: Immediate Breast Reconstruction;   Procedure: Axillary surgery;   Drug: Chemotherapy
37 Recruiting Oncologic Impact of Splenectomy-omitting Radical Pancreatectomy in Well-selected Left-sided Pancreatic Cancer
Conditions: Left-sided Pancreatic Cancer;   Ductal Adenocarcinoma
Interventions: Procedure: Radical Antegrade Modular Pancreatectomy with Splenectomy;   Procedure: Radical Antegrade Modular Pancreatectomy without splenectomy
38 Recruiting The Prone Breast Radiation Therapy Trial
Conditions: Ductal Carcinoma In Situ;   Invasive Breast Cancer
Intervention: Radiation: Radiation Therapy Positioning Intervention
39 Recruiting Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor
Condition: Ductal Carcinoma in Situ
Intervention: Drug: SOM 230 / Pasireotide
40 Recruiting Targeted Intraoperative Radiotherapy United States (TARGIT-US) Registry Trial
Conditions: Malignant Neoplasm of Breast;   Breast Diseases;   Ductal Breast Carcinoma
Intervention: Radiation: Intraoperative radiation therapy (IORT)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years